Jonathan Levitt of Frier Levitt said three federal lawsuits allege CVS Health entities diverted approximately $250 million in 340B program savings from hospitals.
Featured
Industry Pritchett Policy Associates founder Pritchett on biosimilar access: 'PBMs are the problem not patents'
Latest News
State Issues
Cannabis Regulatory Agency seeks new members for diversity, equity, and inclusion workgroup
- Tennessee enacts law banning pharmacy benefit managers from owning pharmacies
- NCPA supports pharmacy bills being marked up in House committees
- NCPA responds to HHS OIG report on vertical integration in Medicare Part D
- South Dakota announces first awards for Rural Health Transformation grant program management
Regulatory
- Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'
- Paragon Health Institute Analyst on 340B: 'The distortionary spread-based pricing of the 340B Program is a major driver of consolidation'
- Steve Forbes on 340B program: 'It has become another Washington racket that enriches hospital conglomerates and pharmacy middlemen'
- Healthcare consultant Roche on 340B program: 'It has been completely perverted by hospitals and other providers to make billions of dollars in profits'
Federal Issues
- American Resolve Action Senior Fellow on 340B reform: Oversight 'could prevent billions of dollars in annual waste, fraud, and abuse'
- WSJ Editorial Board says 340B program has been exploited following North Dakota ruling
- Pacific Research Institute President on 340B program: 'Trump is trying to bring transparency to the bloated 340B program — and hospital lobbyists are panicking'
- ASG President Martin on 340B program: 'Hospitals aren’t just depriving patients of much-needed discounts. They’re also cheating taxpayers'
Industry
- Pritchett Policy Associates founder Pritchett on biosimilar access: 'PBMs are the problem not patents'
- Paragon Health Institute links ACA and HRSA to 340B program growth, calls for reforms
- USC Schaeffer Center Senior Fellow on 340B: 'It's malpractice for Congress having a created a program that is totally out of control to not step in a fix this'
- Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'
Innovation
- Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’
- Fifth vaccine set to enter Phase III clinical trials
- Vaccination efforts for frontline health care workers underway following Pfizer vaccine approval
- PTCB: Pharmacy Technician Certification Board (PTCB) Rolls Out Advanced Certification for Experienced Pharmacy Technicians Who Have Comprehensive Knowledge and Skills
Alerts Sign-up